Cytokinetics
CYTK | NASDAQ
$62.80
-$0.19 (-0.30%)
Nov 2, 2026, 11:38 AM ET · Market open
Market Data
Market Cap $8.73B
Enterprise Value $8.86B
Beta 0.36
Average Volume 1.96M
Shares Outstanding (Diluted) 132.09M
Shares Change YoY 10.57%
Institutional Ownership N/A
Exchange NASDAQ
ISIN US23282W6057
Price Performance
Price Change 1M -4.3%
Price Change 3M -17.9%
Price Change 6M -4.9%
Price Change YTD -1.2%
Price Change 1Y 4.6%
Price Change 3Y 72.9%
Price Change 5Y 71.3%
1M CAGR (ann.) -8.4%
1Y CAGR (ann.) 1.6%
5Y CAGR (ann.) 11.2%
All-Time CAGR 21.1%
Valuation
PE Ratio -8.72
Forward PE N/A
PEG Ratio 0.26
Forward PEG 1.22
PS Ratio 123.41
Forward PS 20.40
PB Ratio -50.48
P/FCF Ratio -15.08
P/Adj. FCF Ratio -12.93
P/OCF Ratio -14.96
EV/Sales 124.89
EV/EBIT -10.62
EV/EBITDA -10.83
EV/FCF -15.26
Earnings Yield -11.5%
FCF Yield -6.6%
Adj. FCF Yield -7.7%
Financial Health
Net Cash $18.6M
Total Debt $1.27B
Cash & Short-Term Investments $1.17B
Total Assets $1.92B
Current Ratio 6.66
Quick Ratio 6.66
Debt / Equity Ratio -7.32
Debt / EBITDA -1.55
Debt / FCF -2.19
OCF / Debt -0.44
Interest Coverage -5.64
Altman Z-Score -1.08
Piotroski F-Score 3
Margins & Profitability
Gross Profit Margin 88.8%
Operating Profit Margin -993.0%
EBITDA Margin -1158.1%
Net Profit Margin -1259.9%
FCF Margin -818.4%
Adj. FCF Margin -954.8%
SBC / Revenue 136.4%
SBC Impact (per share) -16.7%
Returns
Return on Assets -46.5%
Return on Equity 164.0%
Return on Invested Capital -39.3%
Return on Capital Employed -40.4%
Return on Tangible Assets -46.5%
Historical Growth (CAGR)
Revenue CAGR 3Y 92.5%
Revenue CAGR 5Y 4.2%
Revenue CAGR 10Y 8.3%
EPS CAGR 3Y -15.7%
EPS CAGR 5Y -14.9%
EPS CAGR 10Y -18.5%
FCF CAGR 3Y -19.1%
FCF CAGR 5Y -16.6%
FCF CAGR 10Y -26.2%
Analyst Forecasts
Analyst Rating Buy
Analyst Count 15
EPS Growth Next 3Y 36.7%
Revenue Growth Next 3Y 177.9%
Earnings Date Nov 4, 2026
EPS Estimate (next Q) -$1.44
EPS Growth Est (next Q) -43.5%
Revenue Est (next Q) $41.88M
Revenue Growth Est (next Q) 2063.3%
Fair Value Estimates
Graham Number N/A
Graham Upside N/A
Lynch Fair Value N/A
Lynch Upside N/A
Price Target $113.33
Price Target Upside 79.9%
Cash Flow
Operating Cash Flow $-555.45M
Free Cash Flow $-580.71M
Adj. Free Cash Flow $-677.52M
FCF Per Share -$4.40
OCF Per Share -$4.21
OCF/S Ratio -782.8%
Income Statement
Revenue $70.96M
Gross Profit $60.3M
Operating Income $-704.62M
EBITDA $-818.6M
Net Income $-894M
EPS (Diluted) -$7.22
Revenue / Employee $105.44K
Profit / Employee $-1.33M
Employees 673
Add to Watchlist
Select watchlists to add or remove CYTK